|
Facebook
Twitter
Linkedin
|
Natco Pharma launches branded drug for lung cancer
| Medicexchange News - Medicexchange News |
MUMBAI (Reuters) - Natco Pharma Ltd. on Tuesday announced the launch of Pemetrexed, used in the treatment of advanced cell lung cancer.
The injectible drug was being launched under the brand name of Pemnat and would be sold in 20 ml vials.
Shares in Natco Pharma were up 3.4 percent at 120.10 rupees in a weak Mumbai market.
The injectible drug was being launched under the brand name of Pemnat and would be sold in 20 ml vials.
Shares in Natco Pharma were up 3.4 percent at 120.10 rupees in a weak Mumbai market.











